Irmgard Irminger-Finger

Dr Irmgard Irminger-Finger is the founder and co-inventor of BARD1 Life Sciences and its technology. She has more than 15 years of experience in biotech as founder, director, chair, recipient of Swiss startup awards, and one of five finalists in the 2014 European Woman Entrepreneur Award. She is an internationally recognised expert in tumour biology with over 100 publications, multiple international collaborations and many keynote presentations at international conferences. Dr Irminger-Finger has a Masters degree in molecular biology and a PhD in molecular genetics from the University of Zurich, and was an award research fellow at the Harvard University. She holds a tenured faculty position at the University (UNIGE) and University Hospital of Geneva (HUG), and Adjunct Professorship at the University of Western Australia.
Bio last updated 13 Aug 2018

Access to our data for Irmgard Irminger-Finger is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Irmgard Irminger-Finger is linked to 1 organisation which is included in 1 list - Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 31/08/18

1 year TSR5 year TSR
181stBARD1 Life Sciences45%-11%
267thCreso Pharma24%0%
285thMGC Pharmaceuticals22%23%
686thAurora Labs-42%0%
737 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


Executive Director, Chief Scientific Officer
Year started and most recent title


188th↓MGC Pharmaceuticals$403k
189th↑BARD1 Life Sciences$365k
191st-Aurora Labs$330k
192nd↑Creso Pharma$244k
237 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer